Clinical Study
Clinical Analysis of 42 Cases of Ocular Ischemic Syndrome
Table 1
Demography and symptomatology.
| Characteristic | Value (%) |
| Total number of patients | 42 | Male : female ratio | 30 : 12 | Onset age (yr, mean ± SD) | 65.10 ± 10.95 | <45 | 1 | 45~60 | 10 | 61~75 | 29 | >75 | 2 | Ocular symptoms | 42 (100.00) | Amaurosis fugax | 22 (52.38) | Photophobia | 5 (11.90) | Visual loss | 24 (57.14) | Floaters | 20 (47.62) | Metamorphopsia | 3 (7.14) | Phosphenes | 5 (11.90) | Diplopia | 2 (4.76) | Ocular/periorbital pain | 7 (16.67) | Constitutional symptoms | 37 (88.10) | Headache | 20 (47.62) | Syncope | 6 (14.29) | Palpitations | 3 (7.14) | Hemiplegia | 5 (11.90) | Claudication | 3 (7.14) | Systemic diseases and living habit | System arterial hypertension | 37 (88.10) | DM | 24 (57.14) | HLP | 30 (71.43) | Cardiovascular disease | 24 (57.14) | Cerebrovascular disease | 13 (30.95) | Takayasu arteritis | 1 (2.38) | Long-term smoker (>10 yrs) | 16 (38.10) |
|
|
Thirty-five patients (83.33%) had ≥2 symptoms. |